Statistics

Total Visits

Views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial77

Select a period of time:

Number of views in the range

Views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial33

Views

Views
December 20252
January 20260
February 20260
March 20261
April 20264
May 20264
June 202622
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Netherlands4
Italy2
Turkey2
South Africa2
Spain2
Argentina1
Australia1
Bolivia1
Bahamas1
 

Top cities views

Views
Groningen4
Ashburn1
Atlanta1
Brisbane1
Bursa1
Camposol1
Dayton1
Detroit1
Dunstable1
Durban1